Home > Compound List > Product Information
Carbenoxolone_Molecular_structure_CAS_5697-56-3)
Click picture or here to close

Carbenoxolone

Catalog No. DB02329 Name DrugBank
CAS Number 5697-56-3 Website http://www.ualberta.ca/
M. F. C34H50O7 Telephone (780) 492-3111
M. W. 570.7566 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 2073

SYNONYMS

IUPAC name
(2R,4aR,6aS,6bR,8aS,10R,12aR,12bS,14bR)-10-[(3-carboxypropanoyl)oxy]-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid
IUPAC Traditional name
@carbenoxolone

DATABASE IDS

PubChem SID 46508820
PubChem CID 46936354
CAS Number 5697-56-3

PROPERTIES

DETAILS

Description (English)
Item Information
Drug Groups experimental
Description An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity. [PubChem]
References
Sandeep TC, Yau JL, MacLullich AM, Noble J, Deary IJ, Walker BR, Seckl JR: 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6734-9. Epub 2004 Apr 7. [Pubmed]
External Links
Wikipedia

REFERENCES

  • Sandeep TC, Yau JL, MacLullich AM, Noble J, Deary IJ, Walker BR, Seckl JR: 11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6734-9. Epub 2004 Apr 7. Pubmed